1Wang X. Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of re- ceptor tyrosine kinase RET. Biochim Biophys Acta. 2013, 1834 (10) : 2205-2212.
2Goodman KM, Kjaer S, Beuron F, et al. RET Recognition of GDNF-GFRalphal Ligand by a Composite Binding Site Pro- motes Membrane-Proximal Self-Association. Cell Rep. 2014, 8 (6) : 1894-1904.
3Bespalova IN, Angelo GW, Durner M, et al. Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal person- ality disorder in a Puerto Rican family. Psychiatr Genet, 2005, 15 (3): 205-210.
4Michelato A, Bonvicini C, Ventriglia M, et al. 3' UTR (AGG) n repeat of glial cell line-derived neurotrophic factor(GDNF) gene polymorphism in schizophrenia. Neurosci Lett. 2004, 357 (3): 235-237.
5Souza RP, Romano-Silva MA, Lieberman JA, et al. Genetic association of the GDNF alpha-receptor genes with schizophre- nia and clozapine response. J Psychiatr Res. 2010, 44 (11) : 700-706.
6Ma XC, Chen C, Zhu F, et al. Association of the GDNF gene with depression and heroin dependence, but not schizophreni- a, in a Chinese population. Psychiatry Res. 2013, 210 (3) : 1296-1298.
7Tunca Z, Kivircik Akdede B, Ozerdem A, et al. Diverse glial cell line- derived neurotrophic factor (GDNF) support be- tween mania and schizophrenia: A comparative study in four major psychiatric disorders. Eur Psychiatry, 2014.
8Niitsu T, Shirayama Y, Matsuzawa D, et al. Association be- tween serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia. Neurosci Lett. 2014, 575 : 37-41.
9Hyza M, Huttlova J, Kerkovsky M, et al. Psychosis effect on hippocampal reduction in schizophrenia. Prog Neuropsycho- pharmaeol Biol Psychiatry, 2014, 48: 186-192.
10Pertusa M, Garcia-Matas S, Mammeri H, et al. Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol Aging, 2008, 29 (9) : 1366-1379.
二级参考文献14
1Rizos EN,Rontos I,I.askos E,et al.Investigation of serum BDNF levels in drug-naive patients with schizophrenia.Prog Neuro Psy- chopharmacol Biol Psychiatry,2008;32(5) :1308-1311.
2中华医学会精神科分会[M].山东:山东科学技术出版社,2001:75-78.
3Andreasen NC, Olsen S. Negative v positive schizophrenia defini- tion and validation. Arch Gen Psychiatry, 1982;39:789.
4Bishara D, Taylor D. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Drugs,2008;68 (16) :2269-2292.
5Martinowich K, Manji H, Lu B. New insights into BDNF func- tion in depression and anxiety. Nat Neurosci, 2007 ; 10 ( 9 ) : 1089-1093.
